Analyst Price Targets — WELL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 12:54 pm | Michael Goldsmith | UBS | $271.00 | $237.19 | TheFly | Welltower price target raised to $271 from $249 at UBS |
| July 7, 2026 9:26 am | — | Barclays | $254.00 | $232.69 | TheFly | Welltower initiated with an Equal Weight at Barclays |
| June 16, 2026 8:22 pm | David Rodgers | Raymond James | $226.00 | $213.50 | TheFly | Welltower resumed with an Outperform at Raymond James |
| May 22, 2026 10:42 am | Vikram Malhotra | Mizuho Securities | $239.00 | $216.01 | StreetInsider | Welltower, Inc. (WELL) PT Raised to $239 at Mizuho |
| May 21, 2026 2:00 pm | — | Scotiabank | $248.00 | $217.16 | TheFly | Welltower price target raised to $248 from $236 at Scotiabank |
| May 12, 2026 8:22 pm | Jonathan Petersen | Jefferies | $248.00 | $217.50 | TheFly | Welltower price target raised to $248 from $237 at Jefferies |
| May 4, 2026 12:03 pm | — | BMO Capital | $245.00 | $216.27 | TheFly | Welltower price target raised to $245 from $240 at BMO Capital |
| May 4, 2026 11:32 am | — | RBC Capital | $238.00 | $216.91 | TheFly | Welltower price target raised to $238 from $230 at RBC Capital |
| May 4, 2026 9:53 am | — | UBS | $249.00 | $216.91 | TheFly | Welltower price target raised to $249 from $240 at UBS |
| February 24, 2026 1:39 pm | — | RBC Capital | $230.00 | $208.57 | TheFly | Welltower price target raised to $230 from $207 at RBC Capital |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for WELL

America's demographic clock keeps ticking, and the money is following the wrinkles.

Most REITs rallied, but rare bargains still dipped. Major transformations are creating overlooked upside. 5%+ yields offer income while waiting for recovery.

The aging of America has made healthcare stocks an evergreen investment theme. It's also a reason for investors to consider looking at real estate investment trusts (REITs) focused on this area.

Welltower grew revenue and normalized funds from operations by double-digit percentages. Sabra has a dividend that yields above 6%.

Welltower gets a buy for my initial rating, as it presents both a compelling dividend idea and a capital growth idea. Top-line revenue growth is proven over 5 years already, as the portfolio keeps expanding through acquisition, with a recent acquisition in Canada. The stock is favorably covered both by Moody's and Barclays.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for WELL.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
